17-75778652-G-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP7
The NM_005324.5(H3-3B):c.354C>A(p.Val118Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005324.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hemiparkinsonism-hemiatrophy syndrome Uncertain:1
The heterozygous p.Ser147Ter variant in H3F3B was identified by our study in 1 individual with hemiparkinsonism. Trio genome analysis showed this variant to be de novo. The variant has not been previously reported in individuals with hemiparkinsonism and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 147. This alteration occurs within the last exon and is more likely to escape nonsense mediated decay (NMD) and result in a truncated protein. It is of note that loss of function of H3F3B in an autosomal dominant disease has not yet been established based on the criteria laid out in Tayoun, 2018 (PMID: 30192042). Finally, although this gene has been reported in association with hemiparkinsonism, it currently has limited evidence for these associations. In summary, while there is some suspicion for a pathogenic role, the evidence for this gene-disease relationship is limited and therefore the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PS2, PM2 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at